These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 9252201

  • 1. Automated and quantitative immunocytochemical assays of Bcl-2 protein in breast carcinomas.
    Charpin C, Garcia S, Bouvier C, Devictor B, Andrac L, Lavaut MN, Allasia C.
    Br J Cancer; 1997; 76(3):340-6. PubMed ID: 9252201
    [Abstract] [Full Text] [Related]

  • 2. Automated and quantitative immunocytochemical assays of Nm23/NDPK protein in breast carcinomas.
    Charpin C, Bouvier C, Garcia S, Martini F, Andrac L, Lavaut MN, Allasia C.
    Int J Cancer; 1997 Aug 22; 74(4):416-20. PubMed ID: 9291431
    [Abstract] [Full Text] [Related]

  • 3. VLA2 integrin expression in breast carcinomas evaluated by automated and quantitative immunohistochemistry.
    Charpin C, Garcia S, Bergeret D, Andrac L, Horschowski N, Choux R, Lavaut MN.
    Br J Cancer; 1998 Jun 22; 77(12):2274-80. PubMed ID: 9649145
    [Abstract] [Full Text] [Related]

  • 4. ELAM selectin expression in breast carcinomas detected by automated and quantitative immunohistochemical assays.
    Charpin C, Bergeret D, Garcia S, Andrac L, Martini F, Horschowski N, Choux R, Lavaut MN.
    Int J Oncol; 1998 May 22; 12(5):1041-8. PubMed ID: 9538126
    [Abstract] [Full Text] [Related]

  • 5. Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: correlation to messenger RNA expression and to immunohistochemical prognostic indicators.
    Charpin C, Vielh P, Duffaud F, Devictor B, Andrac L, Lavaut MN, Allasia C, Horschowski N, Piana L.
    J Natl Cancer Inst; 1994 Oct 19; 86(20):1539-45. PubMed ID: 7932810
    [Abstract] [Full Text] [Related]

  • 6. Automated and quantitative immunocytochemical assays of CD44v6 in breast carcinomas.
    Charpin C, Garcia S, Bouvier C, Devictor B, Andrac L, Choux R, Lavaut MN, Allasia C.
    Hum Pathol; 1997 Mar 19; 28(3):289-96. PubMed ID: 9042792
    [Abstract] [Full Text] [Related]

  • 7. Inflammatory breast carcinoma: an immunohistochemical study using monoclonal anti-pHER-2/neu, pS2, cathepsin, ER and PR.
    Charpin C, Bonnier P, Khouzami A, Vacheret H, Andrac L, Lavaut MN, Allasia C, Piana L.
    Anticancer Res; 1992 Mar 19; 12(3):591-7. PubMed ID: 1352440
    [Abstract] [Full Text] [Related]

  • 8. p53 quantitative immunocytochemical analysis in breast carcinomas.
    Charpin C, DeVictor B, Andrac L, Amabile J, Bergeret D, LaVaut MN, Allasia C, Piana L.
    Hum Pathol; 1995 Feb 19; 26(2):159-66. PubMed ID: 7860046
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. CD31 quantitative immunocytochemical assays in breast carcinomas. Correlation with current prognostic factors.
    Charpin C, Devictor B, Bergeret D, Andrac L, Boulat J, Horschowski N, Lavaut MN, Piana L.
    Am J Clin Pathol; 1995 Apr 19; 103(4):443-8. PubMed ID: 7726141
    [Abstract] [Full Text] [Related]

  • 12. MIB1 proliferation index in breast infiltrating carcinoma: comparison with other proliferative markers and association with new biological prognostic factors.
    González-Vela MC, Garijo MF, Fernández F, Val-Bernal JF.
    Histol Histopathol; 2001 Apr 19; 16(2):399-406. PubMed ID: 11332695
    [Abstract] [Full Text] [Related]

  • 13. E-cadherin quantitative immunocytochemical assays in breast carcinomas.
    Charpin C, Garcia S, Bouvier C, Devictor B, Andrac L, Choux R, Lavaut M.
    J Pathol; 1997 Mar 19; 181(3):294-300. PubMed ID: 9155715
    [Abstract] [Full Text] [Related]

  • 14. Cytological evaluation of biological prognostic markers from primary breast carcinomas.
    Makris A, Allred DC, Powles TJ, Dowsett M, Fernando IN, Trott PA, Ashley SE, Ormerod MG, Titley JC, Osborne CK.
    Breast Cancer Res Treat; 1997 May 19; 44(1):65-74. PubMed ID: 9164679
    [Abstract] [Full Text] [Related]

  • 15. Mitochondrial UCP4 and bcl-2 expression in imprints of breast carcinomas: relationship with DNA ploidy and classical prognostic factors.
    Gonidi M, Athanassiadou AM, Patsouris E, Tsipis A, Dimopoulos S, Kyriakidou V, Chelidonis G, Athanassiadou P.
    Pathol Res Pract; 2011 Jun 15; 207(6):377-82. PubMed ID: 21621926
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immunohistochemical expression of Bcl-2 protein in breast lesions: correlation with Bax, p53, Rb, C-erbB-2, EGFR and proliferation indices.
    Ioachim EE, Malamou-Mitsi V, Kamina SA, Goussia AC, Agnantis NJ.
    Anticancer Res; 2000 Jun 15; 20(6B):4221-5. PubMed ID: 11205251
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinicopathological study of the expression of hsp27, pS2, cathepsin D and metallothionein in primary invasive breast cancer.
    Ioachim E, Tsanou E, Briasoulis E, Batsis Ch, Karavasilis V, Charchanti A, Pavlidis N, Agnantis NJ.
    Breast; 2003 Apr 15; 12(2):111-9. PubMed ID: 14659340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.